Principal Consultant
Rohan Patil is one such expert who is helping shape the future of healthcare market insights with his deep industry knowledge and forward-thinking approach. Rohan holds a BSc. in Biotechnology and an MBA in Marketing, a combination that allows him to blend scientific understanding with strategic business acumen. With over 5+ years of experience in the market research industry, Rohan has become a trusted analyst in the healthcare domain, where his insights help clients navigate complex trends and make data-driven decisions.
His expertise spans a range of healthcare sub-sectors, but he is particularly passionate about the medical device industry. As healthcare continues to evolve with technological advancements, he is deeply invested in understanding the innovations shaping the medical devices landscape. He has reviewed and contributed to multiple market reports, where his research has played a pivotal role in identifying emerging opportunities and assessing market risks.
With a keen interest in medical technologies and their transformative impact on patient care, he is always at the forefront of industry developments, ready to provide his clients with the insights they need to stay competitive in an increasingly dynamic market.
His unique combination of biotechnology knowledge, marketing expertise, and market research experience makes him a valuable asset to our team, and his work continues to drive actionable, future-focused strategies in the healthcare sector.
No Media Citations Found.
The global implantable sensor orthopedic market size accounted for USD 1.06 billion in 2025 and is predicted to increase from USD 3.06 billion in 2026 to approximately USD 13.17 billion by 2035, expanding at a CAGR of 17.04% from 2026 to 2035. The increasing incidence of accidents and chronic diseases, along with further advancements in healthcare devices, support market growth.
The global ceftriaxone sodium market size accounted for USD 2.85 billion in 2025 and is predicted to increase from USD 2.99 billion in 2026 to approximately USD 4.52 billion by 2035, expanding at a CAGR of 4.80% from 2026 to 2035. The market is driven by the increasing global prevalence of severe bacterial infections.
The US nitrile gloves market size accounted for USD 6.88 billion in 2025 and is predicted to increase from USD 7.38 billion in 2026 to approximately USD 14.22 billion by 2035, expanding at a CAGR of 7.53% from 2026 to 2035. The market growth is attributed to increasing healthcare safety requirements, expanding industrial protection standards, and rising demand for contamination control across pharmaceutical, food processing, and advanced manufacturing industries.
The global US gynecological devices market size accounted for USD 4.17 billion in 2025 and is predicted to increase from USD 4.51 billion in 2026 to approximately USD 9.10 billion by 2035, expanding at a CAGR of 8.12% from 2026 to 2035. The increasing adoption of minimally invasive procedures by healthcare professionals to treat women and technological advancements in hydrothermal ablation devices drive the market growth.
The US cell and gene therapy market size accounted for USD 4.09 billion in 2025 and is predicted to increase from USD 4.74 billion in 2026 to approximately USD 20.00 billion by 2035, expanding at a CAGR of 17.21% from 2026 to 2035. The market is experiencing steady growth due to the rising investments in oncology and rare genetic diseases, strategic alliances between industry players and academic institutions, and personalized solutions for common and rare diseases.
The global neuropharmacology market size accounted for USD 156.80 billion in 2025 and is predicted to increase from USD 168.29 billion in 2026 to approximately USD 311.78 billion by 2035, expanding at a CAGR of 7.20% from 2026 to 2035. The increasing prevalence of neurological diseases, advances in research, and the growing number of clinical trials are key factors driving market growth.
The US pharmaceutical excipients market size accounted for USD 3.08 billion in 2025 and is predicted to increase from USD 3.28 billion in 2026 to approximately USD 5.58 billion by 2035, expanding at a CAGR of 6.12% from 2026 to 2035. The market growth is attributed to rising demand for biologics, specialty drugs, and advanced pharmaceutical formulations requiring high-performance excipients.
The US stroke diagnostic and therapeutic market size accounted for USD 6.40 billion in 2025 and is predicted to increase from USD 6.97 billion in 2026 to approximately USD 15.04 billion by 2035, expanding at a CAGR of 8.92% from 2026 to 2035. The market is driven by the increasing adoption of advanced imaging technologies, an escalating incidence of stroke due to aging, and increasing industrial development.
The US skin repair market size accounted for USD 24.47 billion in 2025 and is predicted to increase from USD 25.98 billion in 2026 to approximately USD 47.43 billion by 2035, expanding at a CAGR of 6.84% from 2026 to 2035. The growing focus on reducing skin problems of the people and the surging deployment of advanced technologies in the cosmetics industry drive the market expansion.
The US dermatology market size accounted for USD 477.75 million in 2025 and is predicted to increase from USD 512.05 million in 2026 to approximately USD 973.78 million by 2035, expanding at a CAGR of 7.38% from 2026 to 2035. The market is driven by the increasing prevalence of chronic skin diseases, growing awareness of skin health, and rising demand for minimally invasive cosmetic procedures.
The US cosmeceuticals market size accounted for USD 16.20 billion in 2025 and is predicted to increase from USD 17.58 billion in 2026 to approximately USD 38.27 billion by 2035, expanding at a CAGR of 8.98% from 2026 to 2035. The market growth is attributed to the rising demand for science-backed skincare, biotechnology-derived ingredients, and personalized beauty solutions.
The US pharmacy automation market size was calculated at USD 1.99 billion in 2025 and is predicted to increase from USD 2.19 billion in 2026 to approximately USD 5.22 billion by 2035, expanding at a CAGR of 10.12% from 2026 to 2035. The market growth is attributed to the rising adoption of intelligent medication management systems, expanding digital healthcare infrastructure, and increasing demand for accurate, high-volume prescription dispensing.
The US electron microscopy market size was calculated at USD 1.40 billion in 2025 and is predicted to increase from USD 1.50 billion in 2026 to approximately USD 2.99 billion by 2035, expanding at a CAGR of 7.88% from 2026 to 2035. The market growth is attributed to rising semiconductor investments, expanding nanotechnology research, and increasing demand for atomic-scale characterization capabilities.
The US brachytherapy market size accounted for USD 345.22 million in 2025 and is predicted to increase from USD 370.79 billion in 2026 to approximately USD 699.86 million by 2035, expanding at a CAGR of 7.32% from 2026 to 2035. The market growth is attributed to rising cancer incidence, increasing adoption of precision radiation therapies, and continuous advancements in brachytherapy technologies.
The global remote neurological monitoring market size was calculated at USD 2.45 billion in 2025 and is predicted to increase from USD 2.81 billion in 2026 to approximately USD 9.69 billion by 2035, expanding at a CAGR of 14.80% from 2026 to 2035. The market is driven by the rising integration of artificial intelligence (AI) and cloud analytics, which enable real-time predictive care and also early detection of neurodegenerative diseases outside traditional hospital settings.
The US active pharmaceutical ingredients market size accounted for USD 41.77 billion in 2025 and is predicted to increase from USD 44.46 billion in 2026 to approximately USD 79.80 billion by 2035, expanding at a CAGR of 6.69% from 2026 to 2035. The increasing demand for precision medicines, along with the technological advancements in the biopharma industry, has driven the market.
The US CAR T-cell therapy market size accounted for USD 2,299.97 million in 2025 and is predicted to increase from USD 2,684.84 million in 2026 to approximately USD 11,510.04 million by 2035, expanding at a CAGR of 17.47% from 2026 to 2035. The market is expanding rapidly due to increasing cancer incidence, growing adoption of personalized medicine, and continuous FDA approvals for new indications and products.
The US infant incubator market size accounted for USD 208.89 million in 2025 and is predicted to increase from USD 224.31 million in 2026 to approximately USD 442.25 million by 2035, expanding at a CAGR of 7.79% from 2026 to 2035. The market is driven by the rising prevalence of preterm births, increasing neonatal intensive care unit (NICU) admissions, advancements in neonatal care technologies, expanding healthcare infrastructure, and growing government investments in maternal and infant healthcare services.
The global CNS drug discovery market size was calculated at USD 9.80 billion in 2025 and is predicted to increase from USD 10.86 billion in 2026 to approximately USD 27.55 billion by 2035, expanding at a CAGR of 10.90% from 2026 to 2035. The rising prevalence of CNS disorders, the integration of AI and ML in drug discovery, and increased government support for clinical trials and funding are significant factors driving market growth.
The US pharmaceutical water market size accounted for USD 7.84 billion in 2025 and is predicted to increase from USD 8.66 billion in 2026 to approximately USD 17.97 billion by 2035, expanding at a CAGR of 8.65% from 2026 to 2035. The market is witnessing substantial growth due to the escalating burden of chronic diseases and the surging demand for high-quality biologics and sterile injectables. This expansion is supported by stringent FDA sterility standards and rapid advancements in water purification technologies, spurring massive investments in pharmaceutical manufacturing infrastructure.
The US biosensors market size accounted for USD 10.87 billion in 2025 and is predicted to increase from USD 11.69 billion in 2026 to approximately USD 20.42 billion by 2035, expanding at a CAGR of 6.51% from 2026 to 2035. The market is driven by the rising prevalence of chronic diseases, increasing demand for point-of-care testing, and advancements in wearable healthcare technologies.
The US bone grafts and substitutes market size accounted for USD 1.31 billion in 2025 and is predicted to increase from USD 01.38 billion in 2026 to approximately USD 2.25 billion by 2035, expanding at a CAGR of 5.56% from 2026 to 2035. Market growth is driven by the increasing prevalence of orthopedic disorders, rising sports injuries, a growing aging population, and expanding demand for minimally invasive surgical procedures.
The US cardiovascular drugs market size accounted for USD 28.42 billion in 2025 and is predicted to increase from USD 29.25 billion in 2026 to approximately USD 37.03 billion by 2035, expanding at a CAGR of 2.68% from 2026 to 2035. The market is witnessing substantial growth, mainly driven by the increasing prevalence of hypertension and heart failure, paired with a high demand for convenient oral medications and next-generation combination therapies that enhance patient compliance.
The US DNA synthesis market size was calculated at USD 1.90 billion in 2025 and is predicted to increase from USD 2.30 billion in 2026 to approximately USD 10.66 billion by 2035, expanding at a CAGR of 18.82% from 2026 to 2035. The growing investments in the biotechnology industry and technological advancements in the genetic engineering sector have accelerated the market expansion.
The US personalized medicine market size was calculated at USD 192.21 billion in 2025 and is predicted to increase from USD 207.15 billion in 2026 to approximately USD 427.17 billion by 2035, expanding at a CAGR of 8.31% from 2026 to 2035. The market is witnessing substantial growth due to the escalating burden of chronic diseases and the high demand for tailored treatments. This growth is supported by NGS and AI integration, spurring research and development in oncology and rare genetic disorders with precise, patient-specific therapies.
The US biotechnology market size accounted for USD 316.41 billion in 2025 and is predicted to increase from USD 361.07 billion in 2026 to approximately USD 1,142.07 billion by 2035, expanding at a CAGR of 13.70% from 2026 to 2035. The market is witnessing substantial growth due to an increasing prevalence of chronic and rare diseases, spurring high demand for precision biologics and gene therapies. Backed by significant research and development investments and FDA approvals, companies are prioritizing targeted platforms that provide highly effective, personalized patient care across critical therapeutic areas.
The US drug discovery market size accounted for USD 26.24 billion in 2025 and is predicted to increase from USD 28.66 billion in 2026 to approximately USD 63.02 billion by 2035, expanding at a CAGR of 9.16% from 2026 to 2035. The market is witnessing substantial growth due to escalating prevalence of chronic conditions, a surging demand for targeted precision therapies, and the integration of AI in preclinical research. This is further supported by significant private and federal research and development investments and robust clinical pipelines across major therapeutic areas.
The global dementia care market size accounted for USD 21.20 billion in 2025 and is predicted to increase from USD 22.97 billion in 2026 to approximately USD 46.97 billion by 2035, expanding at a CAGR of 8.40% from 2026 to 2035. The market is driven by the growing aging population. As life expectancy rises globally, the sheer volume of older adults, who are at the highest risk for neurodegenerative disorders, is leading to an unprecedented increase in dementia diagnoses.
The global stem cell therapy for neurological disorders market size accounted for USD 2.38 billion in 2025 and is predicted to increase from USD 2.81 billion in 2026 to approximately USD 12.67 billion by 2035, expanding at a CAGR of 17.90% from 2026 to 2035. The market is driven by technological advances in stem cell therapy manufacturing, a growing number of clinical trials, and the rising prevalence of neurological disorders.
The US diabetic foot ulcer treatment market size accounted for USD 3.66 billion in 2025 and is predicted to increase from USD 3.87 billion in 2026 to approximately USD 6.58 billion by 2035, expanding at a CAGR of 6.04% from 2026 to 2035. The market is witnessing substantial growth due to the growing diabetic population, along with an aging demographic. The market is further driven by advancements in advanced wound care and regenerative medicine, spurring clinical pipelines for targeted biologics and 3D-bioprinted tissues to improve limb preservation and quality of life.
The US healthcare cloud computing market size accounted for USD 23.58 billion in 2025 and is predicted to increase from USD 27.74 billion in 2026 to approximately USD 117.90 billion by 2035, expanding at a CAGR of 17.46% from 2026 to 2035. The market is witnessing substantial growth due to the rapid digital transformation in healthcare systems, increasing adoption of electronic health records (EHRs), rising demand for scalable data storage, and growing use of AI-enabled analytics to improve patient care, operational efficiency, and data security compliance.
The US biologics market size was calculated at USD 203.60 billion in 2025 and is predicted to increase from USD 223.60 billion in 2026 to approximately USD 525.67 billion by 2035, expanding at a CAGR of 9.95% from 2026 to 2035. The growing adoption of stem cell therapy for the treatment of cancers, along with technological advancements in genetic engineering, has boosted market growth.
The global duchenne muscular dystrophy therapeutics market size accounted for USD 6.80 billion in 2025 and is predicted to increase from USD 7.80 billion in 2026 to approximately USD 26.88 billion by 2035, expanding at a CAGR of 14.80% from 2026 to 2035. The market is driven by advances in genetic therapies and rising demand for rare disease treatments.
The global huntingtons disease market size was calculated at USD 1.42 billion in 2025 and is predicted to increase from USD 1.66 billion in 2026 to approximately USD 6.48 billion by 2035, expanding at a CAGR of 17.20% from 2026 to 2035. The increasing prevalence of Huntington’s disease, along with advances in clinical research and drug development, is a key driver of market growth.
The U.S. cell therapy manufacturing market size accounted for USD 1.71 billion in 2025 and is predicted to increase from USD 1.97 billion in 2026 to approximately USD 6.56 billion by 2035, expanding at a CAGR of 14.39% from 2026 to 2035. The market is driven by increasing clinical development and commercialization of cell-based therapies, rising investments in biopharmaceutical manufacturing infrastructure, and growing demand for scalable, automated production technologies.
The U.S. clinical trial supply and logistics market size accounted for USD 1.54 billion in 2025 and is predicted to increase from USD 1.66 billion in 2026 to approximately USD 3.13 billion by 2035, expanding at a CAGR of 7.35% from 2026 to 2035. The market is driven by the rising number of complex clinical trials, increasing demand for biologics and personalized medicine, and growing need for temperature-controlled and time-sensitive drug distribution across decentralized trial sites.
The global U.S. regenerative medicine market size was calculated at USD 19.77 billion in 2025 and is predicted to increase from USD 24.10 billion in 2026 to approximately USD 102.23 billion by 2035, expanding at a CAGR of 17.86% from 2026 to 2035. The market is driven by the increasing prevalence of chronic and degenerative diseases, rising investment in stem cell and gene therapy research, and growing adoption of advanced tissue engineering and personalized treatment approaches.
The global autoimmune neurological disorders market size accounted for USD 8.50 billion in 2025 and is predicted to increase from USD 9.17 billion in 2026 to approximately USD 17.79 billion by 2035, expanding at a CAGR of 7.90% from 2026 to 2035. This market is accelerating as advancements in targeted, patient-friendly biologics and novel delivery systems transform the long-term management of autoimmune neurological diseases.
The US central lab market size accounted for USD 2.37 billion in 2025 and is predicted to increase from USD 2.58 billion in 2026 to approximately USD 5.19 billion by 2035, expanding at a CAGR of 8.15% from 2026 to 2035. The market is experiencing strong growth driven by rising investments in biopharmaceutical R&D, increasingly complex clinical trial pipelines, and growing demand for standardized, high-quality biomarker testing. This expansion is further supported by the rapid adoption of advanced technologies such as artificial intelligence, laboratory automation, and decentralized clinical trial models, which are improving operational efficiency, data accuracy, and trial turnaround times.
The U.S. perfusion system market size accounted for USD 6,78,407.71 thousand in 2025 and is predicted to increase from USD 7,35,773.48 thousand in 2026 to approximately USD 16,24,531.09 thousand by 2035, expanding at a CAGR of 9.20% from 2026 to 2035. The market is witnessing substantial growth due to the increasing prevalence of cardiovascular diseases, an aging population, and a surge in complex cardiothoracic and organ transplant surgeries.
The global neuroimmunology market size accounted for USD 37.80 billion in 2025 and is predicted to increase from USD 41.15 billion in 2026 to approximately USD 91.88 billion by 2035, expanding at a CAGR of 8.90% from 2026 to 2035. The market is driven by the surging global incidence of neurological and autoimmune disorders, such as multiple sclerosis, Alzheimer's, and Parkinson's, combined with breakthroughs in targeted drug discovery and advanced diagnostic imaging.
The global aquafeed and aquaculture additive market size accounted for USD 78.40 billion in 2025 and is predicted to increase from USD 83.73 billion in 2026 to approximately USD 150.17 billion by 2035, expanding at a CAGR of 6.80% from 2026 to 2035. The market growth is attributed to increasing global seafood consumption, expanding commercial aquaculture production, and rising adoption of functional and sustainable feed technologies.
The U.S. systemic inflammatory response syndrome treatment market size was calculated at USD 4.88 billion in 2025 and is predicted to increase from USD 5.28 billion in 2026 to approximately USD 8.83 billion by 2035, expanding at a CAGR of 6.11% from 2026 to 2035. The market is driven by rising SIRS cases, improved diagnostic technologies, and stronger critical care protocols.
The U.S. insulin pump market size was calculated at USD 2.29 billion in 2025 and is predicted to increase from USD 2.48 billion in 2026 to approximately USD 5.13 billion by 2035, expanding at a CAGR of 8.40% from 2026 to 2035. The market is driven by the integration of artificial intelligence in hybrid closed-loop systems and the growing burden of diabetes.
The U.S. viral vectors and plasmid DNA manufacturing market size accounted for USD 2.84 billion in 2025 and is predicted to increase from USD 3.30 billion in 2026 to approximately USD 11.69 billion by 2035, expanding at a CAGR of 15.20% from 2026 to 2035. The market growth is attributed to increasing gene therapy commercialization, expanding clinical trial activity, and rising investments in advanced biomanufacturing infrastructure.
The global materials for bone implants market size accounted for USD 5.80 billion in 2025 and is predicted to increase from USD 6.24 billion in 2026 to approximately USD 11.96 billion by 2035, expanding at a CAGR of 7.50% from 2026 to 2035. The market is driven by the increasing cases of bone injury and dental problems and advancements in material modification.
The global neuroinflammation market size accounted for USD 8.60 billion in 2025 and is predicted to increase from USD 9.53 billion in 2026 to approximately USD 23.81 billion by 2035, expanding at a CAGR of 10.90% from 2026 to 2035. The increasing geriatric population with neurodegenerative disorders and the rising number of clinical trials around the globe are key drivers of the growth of the market.
The global precision neurology market size was calculated at USD 18.40 billion in 2025 and is predicted to increase from USD 21.07 billion in 2026 to approximately USD 70.63 billion by 2035, expanding at a CAGR of 14.60% from 2026 to 2035. The increasing prevalence of neurological disorders and advances in precision healthcare research are key drivers of market growth.
The global multiple sclerosis diagnostics market size accounted for USD 5.70 billion in 2025 and is predicted to increase from USD 6.20 billion in 2026 to approximately USD 12.88 billion by 2035, expanding at a CAGR of 8.80% from 2026 to 2035. The market is driven by technological advancements in neuroimaging, specifically the use of high-resolution, 3T magnetic resonance imaging (MRI) scanners.
The global multiple sclerosis therapeutics market size accounted for USD 34.80 billion in 2025 and is predicted to increase from USD 37.16 billion in 2026 to approximately USD 66.80 billion by 2035, expanding at a CAGR of 6.90% from 2026 to 2035. The market is driven by rising multiple sclerosis cases, increasing adoption of biologic therapies, and advancements in disease-modifying treatments.
The global CNS biomarkers market size accounted for USD 7.80 billion in 2025 and is predicted to increase from USD 8.81 billion in 2026 to approximately USD 26.13 billion by 2035, expanding at a CAGR of 12.90% from 2026 to 2035. The market is driven by the increasing use of CNS biomarkers, the growing need for understanding various neurological disorders, and rapid advancements in biomarker technologies.
The global amyloid beta therapeutics market size is predicted to increase from USD 6.12 billion in 2026 to approximately USD 26.50 billion by 2035, expanding at a CAGR of 17.80% from 2026 to 2035. The market is driven by rising Alzheimer’s cases and demand for safer targeted therapies.
The global alzheimers disease diagnostics market size accounted for USD 9.40 billion in 2025 and is predicted to increase from USD 10.42 billion in 2026 to approximately USD 26.21 billion by 2035, expanding at a CAGR of 10.80% from 2026 to 2035. The market is driven by the growing demand for early Alzheimer’s detection and minimally invasive, biomarker-based diagnostics.
The global parkinsons disease biomarkers market size accounted for USD 1.35 billion in 2025 and is predicted to increase from USD 1.54 billion in 2026 to approximately USD 4.88 billion by 2035, expanding at a CAGR of 13.80% from 2026 to 2035. The market is driven by the rising demand for early diagnosis and disease-modifying therapies.
The global tau protein targeting therapeutics market size was calculated at USD 1,100.00 million in 2025 and is predicted to increase from USD 1,314.50 million in 2026 to approximately USD 6,534.16 million by 2035, expanding at a CAGR of 19.50% from 2026 to 2035. The rising prevalence of neurodegenerative disorders, along with increased research activities and government healthcare initiatives, is a key driver of market growth.
The global hematopoietic stem cell transplantation market size accounted for USD 11.80 billion in 2025 and is predicted to increase from USD 12.69 billion in 2026 to approximately USD 24.32 billion by 2035, expanding at a CAGR of 7.50% from 2026 to 2035. The rising incidence of blood cancers and advancements in stem cell transplant technologies drive the market.
The global hemophilia market size was estimated at USD 12.50 billion in 2025 and is predicted to increase from USD 13.31billion in 2026 to approximately USD 23.46 billion by 2035, expanding at a CAGR of 6.50% from 2026 to 2035. The market is driven by rising diagnosis rates and advanced prophylactic therapies.
The global non-hodgkin's lymphoma market size was estimated at USD 14.10 billion in 2025 and is predicted to increase from USD 15.00 billion in 2026 to approximately USD 26.22 billion by 2035, expanding at a CAGR of 6.40% from 2026 to 2035. The market is driven by growing prevalence and demand for targeted, convenient treatments, driving significant research and development into novel CAR-T and antibody therapies to improve survival rates and patient convenience.
The global additive manufacturing for medical devices market size accounted for USD 4.60 billion in 2025 and is predicted to increase from USD 5.42 billion in 2026 to approximately USD 23.87 billion by 2035, expanding at a CAGR of 17.90% from 2026 to 2035. The additive manufacturing for medical devices market is driven by demand for patient-specific implants and rapid advancements in biocompatible 3D printing technologies.
The global immunochemistry instruments and reagents market size accounted for USD 26.20 billion in 2025 and is predicted to increase from USD 28.14 billion in 2026 to approximately USD 53.50 billion by 2035, expanding at a CAGR of 7.40% from 2026 to 2035. The immunochemistry instruments & reagents market is driven by growing demand for accurate and rapid diagnostic testing.
The global hospital acquired infection control market size accounted for USD 22.30 billion in 2025 and is predicted to increase from USD 23.79 billion in 2026 to approximately USD 42.65 billion by 2035, expanding at a CAGR of 6.70% from 2026 to 2035. The market is driven by rising incidences of hospital-acquired infections and demand for advanced infection prevention solutions.
The global breast lesion localization methods market size accounted for USD 720.00 million in 2025 and is predicted to increase from USD 770.00 million in 2026 to approximately USD 1,480.00 million by 2035, expanding at a CAGR of 7.47% from 2026 to 2035. The breast lesion localization methods market is driven by rising cases of breast cancer and demand for minimally invasive diagnostics.
The global injectable peptides drugs market size accounted for USD 48.60 billion in 2025 and is predicted to increase from USD 53.07 billion in 2026 to approximately USD 117.18 billion by 2035, expanding at a CAGR of 9.20% from 2026 to 2035. The injectable peptides drug market is driven by the rising prevalence of chronic diseases and the demand for targeted therapies.
The global in vivo CAR-T therapy market size accounted for USD 650.00 million in 2025 and is predicted to increase from USD 861.25 million in 2026 to approximately USD 10,841.07 million by 2035, expanding at a CAGR of 32.50% from 2026 to 2035. The market growth is driven by the rising prevalence of cancer, ongoing advancements in healthcare, and the increasing number of clinical trials focused on in vivo CAR-T therapy.
The global large-scale active stem cell clinical trials market size was calculated at USD 7.20 billion in 2025 and is predicted to increase from USD 8.27 billion in 2026 to approximately USD 28.88 billion by 2035, expanding at a CAGR of 14.90% from 2026 to 2035. The market is growing due to rising clinical trial activity driven by increasing demand for regenerative therapies, advancements in stem cell technologies, and expanding applications in chronic and degenerative diseases.
The global oculoplastic surgery market size was estimated at USD 9.80 billion in 2025 and is predicted to increase from USD 10.46 billion in 2026 to approximately USD 18.74 billion by 2035, expanding at a CAGR of 6.70% from 2026 to 2035. The oculoplastic surgery market is driven by rising demand for cosmetic eye procedures and increasing prevalence of age-related eye disorders.
The global CAR-T therapies for blood cancers market size accounted for USD 6.80 billion in 2025 and is predicted to increase from USD 8.09 billion in 2026 to approximately USD 38.40 billion by 2035, expanding at a CAGR of 18.90% from 2026 to 2035. The CAR-T therapies for blood cancers market is driven by the success of CAR-T cell therapy in treating resistant blood cancers and increasing demand for personalized therapies.
The global DNA-based non-viral technologies market size accounted for USD 5.60 billion in 2025 and is predicted to increase from USD 6.57 billion in 2026 to approximately USD 27.85 billion by 2035, expanding at a CAGR of 17.40% from 2026 to 2035. The market is growing due to rising demand for safer, scalable gene therapies, where non-viral delivery methods offer lower immunogenicity, better repeat dosing potential, and cost-effective manufacturing compared to viral vectors.
The global viral and non-viral vectors market size accounted for USD 9.40 billion in 2025 and is predicted to increase from USD 11.07 billion in 2026 to approximately USD 48.37 billion by 2035, expanding at a CAGR of 17.80% from 2026 to 2035. The viral and non-viral vectors market is driven by rising demand for gene and cell therapies, increasing prevalence of genetic and rare diseases, and rapid advancements in vector engineering technologies.
The global hematology analyzers and reagents market size accounted for USD 7.42 billion in 2025 and is predicted to increase from USD 7.90 billion in 2026 to approximately USD 13.97 billion by 2035, expanding at a CAGR of 6.53% from 2026 to 2035. The increased number of preventive and diagnostic health screenings is the key driver of the global hematology analyzers and reagents market.
The global nerve blocks market size accounted for USD 7.81 billion in 2025 and is predicted to increase from USD 9.00 billion in 2026 to approximately USD 32.15 billion by 2035, expanding at a CAGR of 15.20% from 2026 to 2035. The increased surgical procedure numbers and rapid shift toward opioid-sparing pain management are key drivers of the global nerve blocks market.
The global clinical alarm management market size accounted for USD 3.20 billion in 2025 and is predicted to increase from USD 3.56 billion in 2026 to approximately USD 9.20 billion by 2035, expanding at a CAGR of 11.20% from 2026 to 2035. Factors such as rising alarm fatigue amid government initiatives to promote healthcare IT solutions are expected to boost market growth.
The global chemical API CDMO market size accounted for USD 16.80 billion in 2025 and is predicted to increase from USD 18.36 billion in 2026 to approximately USD 40.88 billion by 2035, expanding at a CAGR of 9.30% from 2026 to 2035. The chemical API CDMO market is driven by increasing outsourcing by pharmaceutical companies, rising complexity of drug molecules, and demand for cost-efficient and scalable manufacturing.
The global chemical drug CDMO market size accounted for USD 13.20 billion in 2025 and is predicted to increase from USD 14.32 billion in 2026 to approximately USD 29.84 billion by 2035, expanding at a CAGR of 8.50% from 2026 to 2035. The market growth is attributed to rising pharmaceutical outsourcing and the increasing need for cost-efficient manufacturing capacity.
The global intracranial pressure monitor market size accounted for USD 2.10 billion in 2025 and is predicted to increase from USD 2.26 billion in 2026 to approximately USD 4.29 billion by 2035, expanding at a CAGR of 7.40% from 2026 to 2035. The market growth is attributed to the rising burden of neurological disorders and increasing adoption of advanced real-time intracranial pressure monitoring technologies in critical care settings.
The global medical device vigilance and patient safety software market size was calculated at USD 1.40 billion in 2025 and is predicted to increase from USD 1.56 billion in 2026 to approximately USD 4.23 billion by 2035, expanding at a CAGR of 11.70% from 2026 to 2035. The growth of the medical device vigilance and patient safety software market is driven by the increasing regulatory compliance requirements, rising focus on patient safety, and the growing need for real-time monitoring and reporting of medical device-related adverse events.
The global metabolic testing equipment market size surpassed USD 1.90 billion in 2025 and is predicted to increase from USD 2.07 billion in 2026 to approximately USD 4.38 billion by 2035, expanding at a CAGR of 8.70% from 2026 to 2035. The market growth is attributed to the rising prevalence of metabolic disorders and advancements in diagnostic technologies.
The global non-clinical information systems market size was estimated at USD 18.20 billion in 2025 and is projected to increase from USD 19.69 billion in 2026 to approximately USD 40.03 billion by 2035, expanding at a CAGR of 8.20% from 2026 to 2035. The market is growing due to rising adoption of digital healthcare solutions that improve operational efficiency, streamline administrative workflows, and support data-driven decision-making across healthcare organizations.
The global atrial fibrillation surgery market size accounted for USD 8.30 billion in 2025 and is predicted to increase from USD 8.91 billion in 2026 to approximately USD 16.95 billion by 2035, expanding at a CAGR of 7.40% from 2026 to 2035. The market growth is attributed to the rising prevalence of atrial fibrillation and the rapid adoption of advanced catheter and surgical ablation technologies.
The global cruciate ligament diagnosis and treatment market size accounted for USD 3.60 billion in 2025 and is predicted to increase from USD 3.86 billion in 2026 to approximately USD 7.22 billion by 2035, expanding at a CAGR of 7.20% from 2026 to 2035. The growing incidence of sports injuries and advancements in surgical techniques are key drivers propelling market expansion.
The global electrophoresis reagents market size accounted for USD 1.80 billion in 2025 and is predicted to increase from USD 1.92 billion in 2026 to approximately USD 3.44 billion by 2035, expanding at a CAGR of 6.70% from 2026 to 2035. The electrophoresis reagents market is driven by rising demand in molecular biology and disease diagnostics.
The global hip reconstruction devices market size accounted for USD 9.30 billion in 2025 and is predicted to increase from USD 9.90 billion in 2026 to approximately USD 17.29 billion by 2035, expanding at a CAGR of 6.40% from 2026 to 2035. The hip reconstruction devices market is driven by the rising prevalence of osteoarthritis and an aging population, which are increasing the demand for joint replacement procedures worldwide.
The global automation, digitization and robotics in cell and gene therapy manufacturing market size accounted for USD 950.00 million in 2025 and is predicted to increase from USD 1,127.65 million in 2026 to approximately USD 5,275.10 million by 2035, expanding at a CAGR of 18.70% from 2026 to 2035. The market is driven by the rising adoption of cutting-edge technologies by both large and small manufacturers to improve the precision of complex therapies.
The global B-cell maturation antigen (BCMA) targeted therapies market size accounted for USD 5.60 billion in 2025 and is predicted to increase from USD 6.62 billion in 2026 to approximately USD 29.81 billion by 2035, expanding at a CAGR of 18.20% from 2026 to 2035. The market is driven by the rising prevalence of multiple myeloma, increasing adoption of advanced immunotherapies such as CAR-T and bispecific antibodies, and strong clinical success of BCMA-targeted treatments in relapsed and refractory patients.
The global inflammatory disease market size accounted for USD 125.00 billion in 2025 and is predicted to increase from USD 133.50 billion in 2026 to approximately USD 241.34 billion by 2035, expanding at a CAGR of 6.80% from 2026 to 2035. The inflammatory disease market is driven by the rising burden of chronic inflammatory disorders and the ongoing need for more effective, targeted therapies.
The global endourology instruments and consumables market size accounted for USD 1.45 billion in 2025 and is predicted to increase from USD 1.56 billion in 2026 to approximately USD 3.10 billion by 2035, expanding at a CAGR of 7.90% from 2026 to 2035. The endourology instruments and consumables market is driven by the rising incidence of kidney stones and the growing adoption of disposable surgical devices.
The global respiratory syncytial virus diagnostic market size accounted for USD 1.50 billion in 2025 and is predicted to increase from USD 1.67 billion in 2026 to approximately USD 4.34 billion by 2035, expanding at a CAGR of 11.20% from 2026 to 2035. This market growth is associated with an elevation in the incidence of respiratory infections, an increasing neonatal population, and a considerable demand for in-vitro diagnostics along with point-of-care services. The pace and precision of RSV detection have been enhanced with the use of diagnostic tools, and this has created several promising prospects for firms in this space.
The global cholestatic pruritus market size accounted for USD 1.40 billion in 2025 and is predicted to increase from USD 1.49 billion in 2026 to approximately USD 2.55 billion by 2035, expanding at a CAGR of 6.20% from 2026 to 2035. The market is expanding due to the increasing prevalence of liver diseases such as ICP and PBS, improved diagnostic methods, and well-developed pipelines for the introduction of novel drugs.
The global amylin analog drugs market size accounted for USD 3.20 billion in 2025 and is predicted to increase from USD 3.47 billion in 2026 to approximately USD 7.10 billion by 2035, expanding at a CAGR of 8.30% from 2026 to 2035. The market is rapidly growing due to the high obesity rate across the globe, technological advancements in developing amylin analogs with high efficiency, and government support in terms of reimbursement policies.
The global day case surgery market size accounted for USD 72.10 billion in 2025 and is predicted to increase from USD 76.79 billion in 2026 to approximately USD 135.34 billion by 2035, expanding at a CAGR of 6.50% from 2026 to 2035. The market is majorly driven by the increase in prevalence of diseases and technological advancements in minimally invasive surgery.
The global ambulatory services market size accounted for USD 89.50 billion in 2025 and is predicted to increase from USD 95.59 billion in 2026 to approximately USD 172.80 billion by 2035, expanding at a CAGR of 6.80% from 2026 to 2035. The ambulatory services market is driven by the rising demand for cost-effective, same-day care and the shift from inpatient to outpatient healthcare settings.
The global inpatient services market size accounted for USD 3.20 trillion in 2025 and is predicted to increase from USD 3.39 trillion in 2026 to approximately USD 5.68 trillion by 2035, expanding at a CAGR of 5.90% from 2026 to 2035. The market is driven by the rising development of hospitals across emerging countries, along with the rising prevalence of chronic ailments and increasing surgical procedures.
The global nursing homes and long-term care facilities market size accounted for USD 532.18 billion in 2025 and is predicted to increase from USD 568.37 billion in 2026 to approximately USD 1,027.47 billion by 2035, expanding at a CAGR of 6.80% from 2026 to 2035. The market growth is attributed to the rapidly aging global population and rising demand for long-term care services.
The global preventive medicine market size accounted for USD 420.00 billion in 2025 and is predicted to increase from USD 454.02 billion in 2026 to approximately USD 915.18 billion by 2035, expanding at a CAGR of 8.10% from 2026 to 2035. The preventive medicine market is driven by the rising prevalence of chronic diseases, growing health awareness, and increasing focus on early intervention.
The global nanomechanical testing market size accounted for USD 1.10 billion in 2025 and is predicted to increase from USD 1.19 billion in 2026 to approximately USD 2.42 billion by 2035, expanding at a CAGR of 8.20% from 2026 to 2035. The nanomechanical testing market is driven by rising demand for precise nanoscale material characterization across advanced industries.
The global stem cell umbilical cord blood market size accounted for USD 18.57 billion in 2025 and is predicted to increase from USD 19.49 billion in 2026 to approximately USD 30.16 billion by 2035, expanding at a CAGR of 4.97% from 2026 to 2035. The market is experiencing healthy growth because of the rising demand for regenerative medicine and sophisticated methodologies of therapy.
The global transradial access market size accounted for USD 2.50 billion in 2025 and is predicted to increase from USD 2.71 billion in 2026 to approximately USD 5.55 billion by 2035, expanding at a CAGR of 8.30% from 2026 to 2035. The market is driven by increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders, and ongoing technological advancements in catheters.
The global flexible and semi-rigid ureteroscopy market size accounted for USD 1.50 billion in 2025 and is predicted to increase from USD 1.61 billion in 2026 to approximately USD 3.09 billion by 2035, expanding at a CAGR of 7.50% from 2026 to 2035. The market is driven by the rising incidence of urologic conditions and ongoing advancements in healthcare technologies.
The global IVF services market size was estimated at USD 50.80 billion in 2025 and is predicted to increase from USD 54.10 billion in 2026 to approximately USD 95.36 billion by 2035, expanding at a CAGR of 6.50% from 2026 to 2035. The market growth is attributed to rising infertility rates, delayed parenthood trends, and continuous advancements in assisted reproductive technologies.
The global veterinary urinalysis market size accounted for USD 1.10 billion in 2025 and is predicted to increase from USD 1.17 billion in 2026 to approximately USD 2.05 billion by 2035, expanding at a CAGR of 6.40% from 2026 to 2035. The market growth is attributed to the rising adoption of preventive animal healthcare and advancements in veterinary urinalysis technologies.